RMD Q1 2022 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena

RMDResMed Inc.

$36B

Q1 2022 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$904M+20.2% YoY

Gross Profit

$506M56.0% margin

Operating Income

$262M29.0% margin

Net Income

$204M22.5% margin

EPS (Diluted)

$1.39

QoQ Revenue Growth

+3.2%

Cash Flow

Operating Cash Flow

-$66M

Free Cash Flow

-$97M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$4.7B

Total Liabilities

$1.7B

Stockholders' Equity

$3.0B

Cash & Equivalents

$276M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$904M	$752M	+20.2%
Gross Profit	$506M	$439M	+15.4%
Operating Income	$262M	$217M	+20.8%
Net Income	$204M	$178M	+14.2%

Revenue Segments

Sleep And Respiratory

$806M89%

Software As Service

$98M11%

Geographic Segments

Us Canada And Latin America

$589M65%

Combined Europe Asia And Other Markets

$315M35%